Skip to main content

Jefferies Financial Group Inc.

Position in COLL — Collegium Pharmaceutical, Inc

CIK 96223 NEW YORK, NY

Position in COLL

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$803,601
-$1,244,711 QoQ
Shares Held
24,300
-45.1% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
7 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in COLL Over Time

Shares Held

Position Value (USD)

Derivatives in COLL

reported options exposure · as of Dec 31, 2022
CallValue
$962,800
CallShares
41,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Jefferies Financial Group Inc. holds $32,795,534 across 16 Drug Manufacturers - Specialty & Generic names. COLL ranks #8 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 COLL
Collegium Pharmaceutical, Inc
This page
24,300 $803,601

All Filings in COLL

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $803,601 24,300
2025-12-31 $2,048,312 44,240
2025-09-30 $4,428,509 126,565
2024-09-30 $1,932,000 50,000
2024-06-30 $11,334,400 352,000
2024-03-31 $1,580,284 40,708
2022-12-31 $667,000 28,750
2022-12-31 $962,800 41,500